Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Komal K. Patel"'
Autor:
Lucas E Redd, Daniel R Nussenzveig, Kyawt Win Shwin, Sidra Ibad, Clay J. Cockerell, Yusuf Chao, Jake Hutto, Haley D Heibel, Komal K. Patel, Kimberly H Laborde
Publikováno v:
The American Journal of dermatopathology. 43(12)
Leukocytoclastic vasculitis (LCV) is a small vessel inflammatory condition considered to be caused by circulating immune complexes and often occurs after an acute infection or exposure to a new medication, although it may be associated with an underl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e65d7d9ca1a1b8a4aa07d77137ebabe2
https://pubmed.ncbi.nlm.nih.gov/34086641
https://pubmed.ncbi.nlm.nih.gov/34086641
Autor:
Timothy J. Brown, Komal K. Patel, Taylor Roberts, Arjun Gupta, Hsiao C. Li, Navid Sadeghi, Eileen Marley
Publikováno v:
Journal of Oncology Practice. 15:e178-e186
BACKGROUND: Rasburicase is a recommended treatment of tumor lysis syndrome and patients at high-risk for developing tumor lysis syndrome. Unfortunately, it is expensive, and unnecessary use raises costs of care. METHODS: Plan, Do, Study, Act methodol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8585d30d965d346b7d3fae6cc5279430
https://doi.org/10.1200/jop.18.00528
https://doi.org/10.1200/jop.18.00528
Publikováno v:
Journal of Clinical Oncology. 36:312-312
312 Background: Rasburicase is recommended for treating established Tumor lysis syndrome (TLS) and patients at high-risk for TLS. Unfortunately, it is an expensive medication and unnecessary use contributes to expenses. Methods: A multidisciplinary q
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::85c884f05d9db787db057749e11c5071
https://doi.org/10.1200/jco.2018.36.30_suppl.312
https://doi.org/10.1200/jco.2018.36.30_suppl.312
Autor:
Lighthizer N; Northeastern State University Oklahoma College of Optometry, Tahlequah, OK, USA., Patel K; Northeastern State University Oklahoma College of Optometry, Tahlequah, OK, USA., Cockrell D; Cockrell Eye Centers, Stillwater, OK, USA., Leung S; Alberta Association of Optometrists, Edmonton, AB, USA., Harle DE; School of Optometry and Vision Sciences, Cardiff University, Cardiff, UK., Varia J; Optometry Department, Moorfields Eye Hospital, London, UK., Niyazmand H; Department of Optometry, University of Western Australia, Perth, Australia., Alam K; Department of Optometry, University of Western Australia, Perth, Australia.
Publikováno v:
Clinical & experimental optometry [Clin Exp Optom] 2024 Jul 24, pp. 1-10. Date of Electronic Publication: 2024 Jul 24.
Autor:
Mei M; Department of Biochemistry, Center for Structural Biology, Vanderbilt University School of Medicine, Nashville, TN 37232., Cupic A; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029.; Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029., Miorin L; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029., Ye C; Texas Biomedical Research Institute, San Antonio, TX 78227., Cagatay T; Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390., Zhang K; Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390.; Shanghai Institute of Immunity and Infection, Chinese Academy of Sciences, Shanghai 200031, China., Patel K; Department of Biochemistry, Center for Structural Biology, Vanderbilt University School of Medicine, Nashville, TN 37232.; Arpirnaut Program, Vanderbilt University School of Medicine, Nashville, TN 37232., Wilson N; Department of Biochemistry, Center for Structural Biology, Vanderbilt University School of Medicine, Nashville, TN 37232., McDonald WH; Department of Biochemistry, Center for Structural Biology, Vanderbilt University School of Medicine, Nashville, TN 37232.; Mass Spectrometry Research Center, Vanderbilt University School of Medicine, Nashville, TN 37232., Crossland NA; Comparative Pathology Laboratory, National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA 02215.; Department of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, MA 02118., Lo M; Comparative Pathology Laboratory, National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA 02215., Rutkowska M; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029.; Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029., Aslam S; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029., Mena I; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029., Martinez-Sobrido L; Texas Biomedical Research Institute, San Antonio, TX 78227., Ren Y; Department of Biochemistry, Center for Structural Biology, Vanderbilt University School of Medicine, Nashville, TN 37232., García-Sastre A; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029.; Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY 10029.; Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029.; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029., Fontoura BMA; Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2024 May 28; Vol. 121 (22), pp. e2314166121. Date of Electronic Publication: 2024 May 20.
Autor:
Zheng A; New York University Rory Meyers College of Nursing, New York, NY, United States., Bergh M; New York University Rory Meyers College of Nursing, New York, NY, United States., Patel Murali K; New York University Rory Meyers College of Nursing, New York, NY, United States.; Hartford Institute for Geriatric Nursing, New York University Rory Meyers College of Nursing, New York, NY, United States., Sadarangani T; New York University Rory Meyers College of Nursing, New York, NY, United States.; Hartford Institute for Geriatric Nursing, New York University Rory Meyers College of Nursing, New York, NY, United States.; New York University Grossman School of Medicine, New York, NY, United States.
Publikováno v:
JMIR formative research [JMIR Form Res] 2024 Mar 01; Vol. 8, pp. e49492. Date of Electronic Publication: 2024 Mar 01.
Autor:
Peter RM; Graduate Program in Pharmaceutical Science, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ, 08854, USA.; Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ, 08854, USA., Chou PJ; Graduate Program in Pharmaceutical Science, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ, 08854, USA.; Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ, 08854, USA., Shannar A; Graduate Program in Pharmaceutical Science, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ, 08854, USA.; Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ, 08854, USA., Patel K; Graduate Program in Pharmaceutical Science, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ, 08854, USA., Pan Y; Graduate Program in Pharmaceutical Science, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ, 08854, USA.; Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ, 08854, USA., Dave PD; Graduate Program in Pharmaceutical Science, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ, 08854, USA.; Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ, 08854, USA., Xu J; Graduate Program in Pharmaceutical Science, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ, 08854, USA.; Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ, 08854, USA., Sarwar MS; Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ, 08854, USA., Kong AT; Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ, 08854, USA. KongT@pharmacy.rutgers.edu.
Publikováno v:
Pharmaceutical research [Pharm Res] 2023 Nov; Vol. 40 (11), pp. 2699-2714. Date of Electronic Publication: 2023 Sep 19.
Autor:
Poudyal M; Department of Biosciences and Bioengineering, IIT Bombay, Powai, Mumbai, 400076, India., Patel K; Department of Biosciences and Bioengineering, IIT Bombay, Powai, Mumbai, 400076, India.; Sunita Sanghi Centre of Aging and Neurodegenerative Diseases, IIT Bombay, Powai, Mumbai, 400076, India., Gadhe L; Department of Biosciences and Bioengineering, IIT Bombay, Powai, Mumbai, 400076, India., Sawner AS; Department of Biosciences and Bioengineering, IIT Bombay, Powai, Mumbai, 400076, India., Kadu P; Department of Biosciences and Bioengineering, IIT Bombay, Powai, Mumbai, 400076, India., Datta D; Department of Biosciences and Bioengineering, IIT Bombay, Powai, Mumbai, 400076, India., Mukherjee S; Department of Biosciences and Bioengineering, IIT Bombay, Powai, Mumbai, 400076, India., Ray S; Department of Biosciences and Bioengineering, IIT Bombay, Powai, Mumbai, 400076, India., Navalkar A; Department of Biosciences and Bioengineering, IIT Bombay, Powai, Mumbai, 400076, India., Maiti S; Department of Biosciences and Bioengineering, IIT Bombay, Powai, Mumbai, 400076, India.; Department of Bioengineering, VIT Bhopal University, Bhopal-Indore Highway, Kothrikalan, Sehore, Madhya Pradesh, 466114, India., Chatterjee D; Department of Biosciences and Bioengineering, IIT Bombay, Powai, Mumbai, 400076, India., Devi J; Department of Biosciences and Bioengineering, IIT Bombay, Powai, Mumbai, 400076, India., Bera R; Department of Biosciences and Bioengineering, IIT Bombay, Powai, Mumbai, 400076, India., Gahlot N; Department of Biosciences and Bioengineering, IIT Bombay, Powai, Mumbai, 400076, India., Joseph J; Department of Biosciences and Bioengineering, IIT Bombay, Powai, Mumbai, 400076, India., Padinhateeri R; Department of Biosciences and Bioengineering, IIT Bombay, Powai, Mumbai, 400076, India., Maji SK; Department of Biosciences and Bioengineering, IIT Bombay, Powai, Mumbai, 400076, India. samirmaji@iitb.ac.in.; Sunita Sanghi Centre of Aging and Neurodegenerative Diseases, IIT Bombay, Powai, Mumbai, 400076, India. samirmaji@iitb.ac.in.
Publikováno v:
Nature communications [Nat Commun] 2023 Oct 04; Vol. 14 (1), pp. 6199. Date of Electronic Publication: 2023 Oct 04.
Autor:
Sullivan K; Sullivan Surgery & Spa, Annapolis, Maryland, USA., Law RM; Propath, Dallas, Texas, USA., Lain E; Sanova Dermatology, Austin, Texas, USA., Jiang LI; SGS Stephens Inc., Richardson, Texas, USA., Acevedo SF; SGS Stephens Inc., Richardson, Texas, USA., Choudhary H; SkinCeuticals, New York, New York, USA., Lee B; L'Oréal Research and Innovation, Clark, New Jersey, USA., Patel K; L'Oréal Research and Innovation, Clark, New Jersey, USA., Lynch S; L'Oréal Research and Innovation, Clark, New Jersey, USA.
Publikováno v:
Journal of cosmetic dermatology [J Cosmet Dermatol] 2023 Oct; Vol. 22 (10), pp. 2755-2764. Date of Electronic Publication: 2023 Jul 18.
Autor:
Sternberg MR; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Johnson A; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., King J; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Ali AR; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Linde L; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Awofeso AO; Community Health Administration, DC Department of Health, Washington, District of Columbia, United States of America., Baker JS; Division of Population Health, Utah Department of Health and Human Services, Salt Lake City, Utah, United States of America., Bayoumi NS; Communicable Disease Service, New Jersey Department of Health, Trenton, New Jersey, United States of America., Broadway S; Division of Disease Control and Health Protection, Florida Department of Health, Tallahassee, Florida, United States of America., Busen K; Division of Communicable Disease, Michigan Department of Health and Human Services, Lansing, Michigan, United States of America., Chang C; Communicable Disease Service, New York City Department of Health and Mental Hygiene, Long Island City, New York, United States of America., Cheng I; Bureau of Immunization, New York City Department of Health and Mental Hygiene, Long Island City, New York, United States of America., Cima M; Epidemilogy, Arkansas Department of Health, Little Rock, Arkansas, United States of America., Collingwood A; Division of Population Health, Utah Department of Health and Human Services, Salt Lake City, Utah, United States of America., Dorabawila V; Bureau of Surveillance and Data Systems, Division of Epidemiology, Albany, New York State Department of Health, New York, NY, United States of America., Drenzek C; Acute Epidemiology, Georgia Department of Public Health, Atlanta, Georgia, United States of America., Fleischauer A; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Gent A; Division of Disease Control and Health Protection, Florida Department of Health, Tallahassee, Florida, United States of America., Hartley A; Communicable and Environmental Diseases and Emergency Preparedness, Nashville, Tennessee Department of Health, Nashville, Tennessee, United States of America., Hicks L; Bureau of Infectious Disease and Services, Arizona Department of Health Services, Phoenix, Arizona, United States of America., Hoskins M; Communicable Disease, North Carolina Department of Health and Human Services, Raleigh, North Carolina, United States of America., Jara A; Acute Epidemiology, Georgia Department of Public Health, Atlanta, Georgia, United States of America., Jones A; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Khan SI; Communicable Disease Service, New Jersey Department of Health, Trenton, New Jersey, United States of America., Kamal-Ahmed I; Division of Public Health, Nebraska Department of Health and Human Services, Lincoln, Nebraska, United States of America., Kangas S; COVID-19 Data and Surveillance Unit, Wisconsin Department of Health Services, Madison, Wisconsin, United States of America., Kanishka F; Division of Public Health, Nebraska Department of Health and Human Services, Lincoln, Nebraska, United States of America., Kleppinger A; Epidemiology and Infectious Disease Section, Connecticut Department of Public Health, Hartford, Connecticut, United States of America., Kocharian A; COVID-19 Data and Surveillance Unit, Wisconsin Department of Health Services, Madison, Wisconsin, United States of America., León TM; Center for Infectious Diseases, California Department of Public Health, Sacramento, California, United States of America., Link-Gelles R; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Lyons BC; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Masarik J; Community Health Administration, DC Department of Health, Washington, District of Columbia, United States of America., May A; Bureau of Epidemiology and Public Health Informatics, Kansas Department of Health and Environment, Kansas, Missouri, United States of America., McCormick D; Epidemilogy, Arkansas Department of Health, Little Rock, Arkansas, United States of America., Meyer S; Infectious Disease Epidemiology, Prevention and Control Division, Minnesota Department of Health, Saint Paul, Minnesota, United States of America., Milroy L; Disease Epidemiology and Prevention Division, Indiana Department of Health, Indianapolis, Indiana, United States of America., Morris KJ; Infectious Disease Epidemiology, Prevention and Control Division, Minnesota Department of Health, Saint Paul, Minnesota, United States of America., Nelson L; Center for Infectious Diseases, California Department of Public Health, Sacramento, California, United States of America., Omoike E; Division of Communicable Disease, Michigan Department of Health and Human Services, Lansing, Michigan, United States of America., Patel K; Acute Epidemiology, Georgia Department of Public Health, Atlanta, Georgia, United States of America., Pietrowski M; Division of Disease Control, Philadelphia Department of Public Health, Philadelphia, Pennsylvania, United States of America., Pike MA; Disease Control and Public Health Response Division, Colorado Department of Public Health and Environment, Denver, Colorado, United States of America., Pilishvili T; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Peterson Pompa X; Bureau of Infectious Disease and Services, Arizona Department of Health Services, Phoenix, Arizona, United States of America., Powell C; Epidemiology and Infectious Disease Section, Connecticut Department of Public Health, Hartford, Connecticut, United States of America., Praetorius K; CDC Foundation, Atlanta, Georgia, United States of America., Rosenberg E; Bureau of Surveillance and Data Systems, Division of Epidemiology, Albany, New York State Department of Health, New York, NY, United States of America., Schiller A; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Smith-Coronado ML; Disease Control and Public Health Response Division, Colorado Department of Public Health and Environment, Denver, Colorado, United States of America., Stanislawski E; Epidemiology and Response Division, New Mexico Department of Health, Santa Fe, New Mexico, United States of America., Strand K; Division of Public Health, Nebraska Department of Health and Human Services, Lincoln, Nebraska, United States of America., Tilakaratne BP; Community Health Administration, DC Department of Health, Washington, District of Columbia, United States of America., Vest H; Disease Epidemiology and Prevention Division, Indiana Department of Health, Indianapolis, Indiana, United States of America., Wiedeman C; Communicable and Environmental Diseases and Emergency Preparedness, Nashville, Tennessee Department of Health, Nashville, Tennessee, United States of America., Zaldivar A; Bureau of Epidemiology and Public Health Informatics, Kansas Department of Health and Environment, Kansas, Missouri, United States of America., Silk B; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Scobie HM; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Publikováno v:
PloS one [PLoS One] 2023 Sep 20; Vol. 18 (9), pp. e0291678. Date of Electronic Publication: 2023 Sep 20 (Print Publication: 2023).